ISSN: 2167-7948
+44 1300 500008
Department of Biomedical Sciences, Yonsei University, Seoul, South Korea
Dr. Briyan Liang is a leading researcher and educator in the Abteilung für Biomedizinische Wissenschaften at Yonsei-Universität, Seoul, South Korea. With a strong background in molecular biology and translational research, Dr. Liang has made significant strides in the fields of cancer biology and personalized medicine, focusing on the molecular mechanisms driving tumor progression and therapeutic resistance. Dr. Liang earned their doctorate in biomedical sciences and completed postdoctoral training at internationally renowned institutions, specializing in oncogenomics and targeted therapies. Their research focuses on identifying genetic and epigenetic alterations in cancer cells and developing precision medicine approaches to improve patient outcomes. Dr. Liang’s pioneering work in biomarkers and drug resistance mechanisms has shaped modern strategies for combating aggressive and refractory cancers. As a professor, Dr. Liang is deeply committed to fostering academic excellence and scientific curiosity among students. They have been instrumental in developing interdisciplinary programs at Yonsei University, emphasizing the integration of bioinformatics, genomics, and experimental biology. Dr. Liang’s mentorship has guided numerous students and researchers toward successful careers in biomedical sciences.
Opinion Article
Advancing Precision Oncology: The Role of Cancer Stem Cells in Thyroid Cancer Treatment
Author(s): Briyan Liang*
DOI:
10.35841/2167-7948.24.13.348